BR9909268A - C11 oximil e hidroxilamino prostaglandinas úteis como agonistas de fp - Google Patents
C11 oximil e hidroxilamino prostaglandinas úteis como agonistas de fpInfo
- Publication number
- BR9909268A BR9909268A BR9909268-9A BR9909268A BR9909268A BR 9909268 A BR9909268 A BR 9909268A BR 9909268 A BR9909268 A BR 9909268A BR 9909268 A BR9909268 A BR 9909268A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- agonists
- useful
- oximyl
- glaucoma
- Prior art date
Links
- 239000000556 agonist Substances 0.000 title abstract 2
- -1 hydroxylamino prostaglandins Chemical class 0.000 title 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 208000020084 Bone disease Diseases 0.000 abstract 2
- 208000010412 Glaucoma Diseases 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 150000003949 imides Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003180 prostaglandins Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Patente de Invenção: <B>"C~ 11~ OXIMIL E HIDROXILAMINO PROSTAGLANDINAS úTEIS COMO AGONISTAS DE FP"<D>. A invenção fornece novos análogos de prostaglandina. Em particular, a presente invenção refere-se a compostos tendo uma estrutura de acordo com a fórmula (I) onde R~ 1~, R~ 2~, R~ 3~, R~ 4~, R~ 5~, R~ 6~, W, X, Z, a, b, p e p estão definidos abaixo. Esta invenção também inclui isómeros óticos, diastereómeros e enantiómeros de fórmula (I), e sais farmaceuticamente aceitáveis, amidas, ésteres e imidas biohidrolisáveis dos mesmos. Os compostos da presente invenção são úteis para o tratamento de várias doenças e condições, tais como distúrbios ósseos e glaucoma. Por conseguinte, a invenção fornece ainda composições farmacêuticas compreendendo esses compostos. A invenção fornece ainda métodos de tratamento para distúrbios ósseos e glaucoma usando esses compostos ou as composições contendo os mesmos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8021698P | 1998-03-31 | 1998-03-31 | |
| PCT/IB1999/000480 WO1999050242A1 (en) | 1998-03-31 | 1999-03-22 | C11 oxymyl and hydroxylamino prostaglandins useful as fp agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9909268A true BR9909268A (pt) | 2001-09-04 |
Family
ID=22155990
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9909268-9A BR9909268A (pt) | 1998-03-31 | 1999-03-22 | C11 oximil e hidroxilamino prostaglandinas úteis como agonistas de fp |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1066254B1 (pt) |
| JP (1) | JP2002509916A (pt) |
| KR (1) | KR20010042285A (pt) |
| CN (1) | CN1295559A (pt) |
| AR (1) | AR018590A1 (pt) |
| AT (1) | ATE296284T1 (pt) |
| AU (1) | AU749540B2 (pt) |
| BR (1) | BR9909268A (pt) |
| CA (1) | CA2324590C (pt) |
| DE (1) | DE69925475T2 (pt) |
| ES (1) | ES2244208T3 (pt) |
| HU (1) | HUP0103403A3 (pt) |
| IL (1) | IL138447A0 (pt) |
| NO (1) | NO20004903L (pt) |
| NZ (1) | NZ506855A (pt) |
| PE (1) | PE20000351A1 (pt) |
| PL (1) | PL343125A1 (pt) |
| SK (1) | SK14722000A3 (pt) |
| TR (1) | TR200002795T2 (pt) |
| WO (1) | WO1999050242A1 (pt) |
| ZA (1) | ZA992394B (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE281432T1 (de) | 1999-03-05 | 2004-11-15 | Univ Duke | C-16 ungesätigte fp-selektive prostaglandin analoge |
| US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| KR100437873B1 (ko) * | 2001-05-08 | 2004-06-26 | 연성정밀화학(주) | 프로스타글란딘 유도체의 제조방법 및 그의 입체특이적출발물질 |
| US20060135609A1 (en) | 2004-10-21 | 2006-06-22 | Duke University | Ophthamological drugs |
| WO2008060799A2 (en) * | 2006-11-09 | 2008-05-22 | Bausch & Lomb Incorporated | Synthesis of selected stereoisomers of certain substituted alcohols |
| US20110293549A1 (en) | 2009-02-03 | 2011-12-01 | Athena Cosmetics, Inc. | Composition, method and kit for enhancing hair |
| CN102101835B (zh) * | 2009-12-16 | 2015-07-22 | 武汉启瑞药业有限公司 | ***素衍生物及其中间体的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3538120A (en) * | 1967-05-22 | 1970-11-03 | Ciba Geigy Corp | Cyclopentyl-alkanoic acids |
| US3798275A (en) * | 1972-04-05 | 1974-03-19 | Ciba Geigy Corp | Etherified mercapto-methoxyamines |
-
1999
- 1999-03-22 SK SK1472-2000A patent/SK14722000A3/sk unknown
- 1999-03-22 JP JP2000541147A patent/JP2002509916A/ja not_active Withdrawn
- 1999-03-22 ES ES99942611T patent/ES2244208T3/es not_active Expired - Lifetime
- 1999-03-22 DE DE69925475T patent/DE69925475T2/de not_active Expired - Fee Related
- 1999-03-22 NZ NZ506855A patent/NZ506855A/xx unknown
- 1999-03-22 AT AT99942611T patent/ATE296284T1/de not_active IP Right Cessation
- 1999-03-22 TR TR2000/02795T patent/TR200002795T2/xx unknown
- 1999-03-22 HU HU0103403A patent/HUP0103403A3/hu unknown
- 1999-03-22 CN CN99804644A patent/CN1295559A/zh active Pending
- 1999-03-22 PL PL99343125A patent/PL343125A1/xx unknown
- 1999-03-22 KR KR1020007010828A patent/KR20010042285A/ko not_active Application Discontinuation
- 1999-03-22 EP EP99942611A patent/EP1066254B1/en not_active Expired - Lifetime
- 1999-03-22 BR BR9909268-9A patent/BR9909268A/pt not_active IP Right Cessation
- 1999-03-22 IL IL13844799A patent/IL138447A0/xx unknown
- 1999-03-22 AU AU32702/99A patent/AU749540B2/en not_active Ceased
- 1999-03-22 WO PCT/IB1999/000480 patent/WO1999050242A1/en not_active Application Discontinuation
- 1999-03-22 CA CA002324590A patent/CA2324590C/en not_active Expired - Fee Related
- 1999-03-29 ZA ZA9902394A patent/ZA992394B/xx unknown
- 1999-03-30 AR ARP990101443A patent/AR018590A1/es unknown
- 1999-03-30 PE PE1999000251A patent/PE20000351A1/es not_active Application Discontinuation
-
2000
- 2000-09-29 NO NO20004903A patent/NO20004903L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69925475D1 (de) | 2005-06-30 |
| NO20004903L (no) | 2000-11-29 |
| TR200002795T2 (tr) | 2001-01-22 |
| CN1295559A (zh) | 2001-05-16 |
| KR20010042285A (ko) | 2001-05-25 |
| AU749540B2 (en) | 2002-06-27 |
| IL138447A0 (en) | 2001-10-31 |
| EP1066254A1 (en) | 2001-01-10 |
| AU3270299A (en) | 1999-10-18 |
| PL343125A1 (en) | 2001-07-30 |
| NO20004903D0 (no) | 2000-09-29 |
| HUP0103403A2 (hu) | 2002-01-28 |
| ES2244208T3 (es) | 2005-12-01 |
| CA2324590A1 (en) | 1999-10-07 |
| HUP0103403A3 (en) | 2002-12-28 |
| DE69925475T2 (de) | 2005-11-17 |
| JP2002509916A (ja) | 2002-04-02 |
| SK14722000A3 (sk) | 2001-07-10 |
| CA2324590C (en) | 2006-06-13 |
| ZA992394B (en) | 1999-09-30 |
| EP1066254B1 (en) | 2005-05-25 |
| AR018590A1 (es) | 2001-11-28 |
| WO1999050242A1 (en) | 1999-10-07 |
| PE20000351A1 (es) | 2000-06-22 |
| NZ506855A (en) | 2003-02-28 |
| ATE296284T1 (de) | 2005-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9811779A (pt) | Tetrahidro prostaglandina s substituìdas por c16-c20 aromáticos úteis como agonistas fp | |
| BR9811774A (pt) | Tetraidroprostaglandinas aromáticas substituìdas por c16-c20 úteis como agonistas fp | |
| BR9812631A (pt) | Tetraidro prostaglandinas substituìdas por c16-c20 aromáticos úteis como agonistas de fp | |
| BR9713186A (pt) | Inibidores de metaloprotease 1,3-diheterocìclicos | |
| BR9909620A (pt) | Inibidores de metaloproteases de hidroxamato de pirrolidina substituìdo | |
| BR9810841A (pt) | Inibidores de metaloprotease alicìclicos | |
| EA200000682A1 (ru) | Новые ацилгуанидиновые производные в качестве ингибиторов резорбции костной ткани и антагонистов витронектиновых рецепторов | |
| BR9813028A (pt) | Agonistas de prostaglandina e seu uso para tratar distúrbios nos ossos | |
| CO4910163A1 (es) | Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas | |
| BR9713465A (pt) | Inibidores metalotprotease de amina cìclica sibstituìda | |
| BR9804437A (pt) | Compostos para a osteoporose | |
| PT1058683E (pt) | Inibidores da farnesil-transferase com uma estrutura de piperidina e seu processo de preparacao | |
| BR0008776A (pt) | Análogos de prostaglandinas fp-seletivosinsaturados c16 | |
| BR0008778A (pt) | Análogos de prostaglandinas seletivos para fpc16 insaturados | |
| EA200000785A1 (ru) | Новые сульфонамидные производные в качестве ингибиторов рассасывания костной ткани и ингибиторов адгезии клеток | |
| CO5180578A1 (es) | Inhibidores de metaloproteasas dihetero substituida que son efectivos en el tratamiento de condiciones caracterizadas por la actividad excesiva de estas enzimas | |
| BR9914158A (pt) | Composição antibiótica para o tratamento dos olhos, ouvidos e nariz | |
| ES2202156T3 (es) | Nuevos analogos de 2-descarboxi-2-fosfinico prostaglandina f. | |
| BR9909268A (pt) | C11 oximil e hidroxilamino prostaglandinas úteis como agonistas de fp | |
| BR9909267A (pt) | C11 oximila e prostaglandinas hidroxilamino úteis como medicamentos | |
| BR9503572A (pt) | Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença | |
| DE69819539D1 (de) | Antithrombotische mittel | |
| BR9905974A (pt) | Derivados de ácido aril carboxìlico e tetrazol | |
| CO5271694A1 (es) | Inhibidores beta di-sustituidos de las metaloproteasas, composiciones farmaceuticas que los contienen y procedimientos para su aplicacion | |
| EA199801015A1 (ru) | Производные пиперидинуксусной кислоты и их применение при лечении тромботических нарушений |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5O 6O, 7O E 8O ANUIDADES |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007. |